Lower urinary tract symptoms/benign prostatic hypertrophy and vascular function: Role of the nitric oxide-phosphodiesterase type 5-cyclic guanosine 3′,5′-monophosphate pathway
2017 ◽
Vol 24
(6)
◽
pp. 412-424
◽
2013 ◽
Vol 39
(4)
◽
pp. 264-269
2018 ◽
Vol 6
(10)
◽
pp. 3346
2014 ◽
pp. 113-128